Preoperative serum levels of angiogenesis factors, for example, such as placenta growth factor (PIGF), combined with circulating tumor cell levels, have been identified as independent predictors of poor recurrence-free survival in a series of 107 patients [31]. The gene discussed is PGF; the disease is neoplasm.